testicular cancer	is a	germ cell tumor
testicular cancer	is a	malignant tumor
testicular cancer	arises from	germ cells
testicular cancer	occurs in	young men
testicular cancer	age distribution	young adults
family history	increases risk of	testicular cancer
Klinefelter syndrome	increases risk of	testicular cancer
infertility	associated with	testicular cancer
testicular cancer	presents with	painless testicular mass
testicular cancer	presents with	testicular swelling
testicular cancer	presents with	testicular lump
alpha-fetoprotein	is elevated in	testicular cancer
beta-hCG	is elevated in	testicular cancer
LDH	is elevated in	testicular cancer
seminoma	is a	germ cell tumor subtype
non-seminomatous germ cell tumor	is a	germ cell tumor subtype
embryonal carcinoma	is a	non-seminomatous germ cell tumor
yolk sac tumor	is a	non-seminomatous germ cell tumor
choriocarcinoma	is a	non-seminomatous germ cell tumor
teratoma	is a	non-seminomatous germ cell tumor
scrotal ultrasound	used for	diagnosis of testicular cancer
CT scan	used for	staging of testicular cancer
MRI	used for	staging of testicular cancer
PET-CT	used for	staging of testicular cancer
alpha-fetoprotein	used as	tumor marker in testicular cancer
beta-hCG	used as	tumor marker in testicular cancer
LDH	used as	tumor marker in testicular cancer
testicular cancer	staged by	imaging studies
testicular cancer	staged by	AJCC stage
orchiectomy	performed to	remove testis
orchiectomy	removes	testis
orchiectomy	provides	tissue for pathology
retroperitoneal lymph node dissection	performed to	remove nodal metastases
BEP chemotherapy	regimen for	testicular cancer
bleomycin	causes	pulmonary toxicity
etoposide	causes	myelosuppression
cisplatin	causes	nephrotoxicity
cisplatin	causes	ototoxicity
BEP chemotherapy	includes	bleomycin
BEP chemotherapy	includes	etoposide
BEP chemotherapy	includes	cisplatin
seminoma	treated with	radiotherapy
radiotherapy	used for	seminoma
non-seminomatous germ cell tumor	treated with	chemotherapy
surveillance	is management option for	stage I testicular cancer
sperm banking	recommended for	patients with testicular cancer
fertility preservation	includes	sperm cryopreservation
bilateral orchiectomy	causes	hypogonadism
hormone replacement therapy	used for	hypogonadism
testosterone	produced by	testes
testosterone replacement therapy	maintains	secondary sexual characteristics
testicular cancer	metastasizes to	lungs
testicular cancer	metastasizes to	liver
testicular cancer	metastasizes to	brain
testicular cancer	metastasizes to	bone
lung metastasis	presents with	cough
liver metastasis	presents with	abdominal pain
brain metastasis	presents with	headache
bone metastasis	presents with	bone pain
stage I disease	has	favorable prognosis
stage II disease	has	intermediate prognosis
stage III disease	has	poor prognosis
tumor marker normalization	indicates	response to therapy
complete remission	achieved by	chemotherapy
partial remission	achieved by	chemotherapy
surgery first approach	used for	localized disease
immunotherapy	not approved for	testicular cancer
late effects	include	secondary malignancies
gonadotoxic therapy	increases risk of	infertility
adolescents	require	fertility counseling
sperm count	declines after	chemotherapy
late relapse	occurs after	two years
secondary malignancy	risk after	chemotherapy
clinical guidelines	update	recommendations for testicular cancer
sperm cryopreservation	preserves	fertility potential
age at diagnosis	influences	prognosis
unilateral orchiectomy	preserves	testosterone production
bilateral orchiectomy	causes	hypogonadism
clinical guidelines	update	recommendations for testicular cancer
fertility preservation	preserves	fertility potential
paternity	preserved by	fertility preservation
contralateral testicular tumor	occurs in	rare cases
inguinal orchiectomy	preferred approach for	testicular cancer
scrotal violation	avoided in	testicular cancer surgery
RPLND	indicated for	non-seminomatous germ cell tumor with metastasis
late relapse	occurs after	two years
sperm count	declines after	chemotherapy
testicular cancer	survival	high
metastasis pattern	includes	retroperitoneal lymph nodes
retroperitoneal lymph nodes	drainage	testicular venous drainage
cancer staging	updated by	imaging results
marker normalization	correlates with	treatment success
clinical trial	offers	novel therapies for testicular cancer
adolescent patients	require	fertility counseling
post-therapy surveillance	reduces	recurrence risk
immunotherapy	not approved for	testicular cancer
late effects	include	secondary malignancies
gonadotoxic therapy	increases risk of	infertility
age at diagnosis	influences	prognosis
unilateral orchiectomy	preserves	testosterone production
bilateral orchiectomy	causes	hypogonadism
clinical guidelines	update	recommendations for testicular cancer
fertility preservation	preserves	fertility potential
